These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20509255)

  • 1. [Groundbreaking new data for HIV and hepatitis B and C. What will change in 2010?].
    Jablonowski H; Mauss S
    MMW Fortschr Med; 2010 Apr; 152(17):26. PubMed ID: 20509255
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the treatment of hepatitis B and C co-infection in HIV patients].
    Mauss S
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():27-9. PubMed ID: 15373041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis C and HIV. Current therapeutic options].
    Mauss S
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():46-9. PubMed ID: 11373779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dual infection with HIV and HCV. Focus on antiviral therapy].
    MMW Fortschr Med; 2001 Oct; 143(40):54. PubMed ID: 11692848
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV & hepatitis C: treatment.
    WORLD; 2002 May; (133):4-5. PubMed ID: 12064298
    [No Abstract]   [Full Text] [Related]  

  • 6. Entering the new era of therapy for HBV and HCV infections.
    Peters MG; Perrillo RP; Jacobson IM; Ross DB; Doo EC; Murray JS; Wong JB
    J Fam Pract; 2010 Apr; 59(4 Suppl):S51-8. PubMed ID: 20398591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiviral therapy for chronic viral hepatitis B and C].
    Iino S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():787-91. PubMed ID: 12722317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral therapy in children with chronic hepatitis B and children with chronic hepatitis C].
    Zhang H; Zhu S
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):563-6. PubMed ID: 25224229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pegylated alfa-2a in hepatitis B. Fewer injections with better results?].
    MMW Fortschr Med; 2003 Nov; 145(48):63. PubMed ID: 14725009
    [No Abstract]   [Full Text] [Related]  

  • 10. Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.
    Moreno A; Quereda C; Fortún J; Bárcena R; Pérez-Elías MJ; Casado JL; Rodríguez-Sagrado MA; Mateos ML; Blesa C; Moreno S
    AIDS; 2010 May; 24(8):1231-3. PubMed ID: 20421744
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist.
    Raimondo G; Saitta C
    J Hepatol; 2008 Nov; 49(5):677-9. PubMed ID: 18804888
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patient, 50, with chronic hepatitis C genotype 1 infection. Therapeutic success despite poor prognosis].
    Klinker H
    MMW Fortschr Med; 2003 Oct; 145(41):39-40. PubMed ID: 14655480
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two-step interferon rebound therapy].
    Kato M; Yuki N; Iyoda K; Yamamoto K; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):497-501. PubMed ID: 15359849
    [No Abstract]   [Full Text] [Related]  

  • 14. Do differences in pegylation of interferon alfa matter?
    Zeuzem S
    Gastroenterology; 2010 Jan; 138(1):34-6. PubMed ID: 19932662
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic hepatitis C: efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients].
    Lee YJ
    Korean J Hepatol; 2008 Dec; 14(4):443-5. PubMed ID: 19119239
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pegylated interferon alfa-2a. Improved prognosis in hepatitis C].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395712
    [No Abstract]   [Full Text] [Related]  

  • 18. Age and prediction of sustained virological response to hepatitis C virus (HCV) infection treatment based on 28-day decrease in HCV RNA levels.
    Antonucci G; Angeletti C; Vairo F; Longo MA; Girardi E
    J Infect Dis; 2009 Nov; 200(9):1484-5; author reply 1485. PubMed ID: 19817588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of viral hepatitis in children].
    Jaklin Kekez A
    Acta Med Croatica; 2009 Dec; 63(5):459-62. PubMed ID: 20198908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic hepatitis C. First treatment].
    Colombato L; Descalzi V; Gadano A
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S37-9. PubMed ID: 20214297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.